KRISHNASWAMY YELESWARAM plan to sell securities of Rapport Therapeutics, Inc. under Form 144

KRISHNASWAMY YELESWARAM filed Form 144 to notify SEC of plan to sell 19365 units of Rapport Therapeutics, Inc. securities around 2026-04-13, with aggregate market value of $661,702.05. The total outstanding units is 47792943.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in past 3 months include: On 04/10/2026, sold 500 units for $17490.00; On 04/08/2026, sold 360 units for $12564.00; On 03/25/2026, sold 10115 units for $303354.24;